Franchisee count has hit a record 11,730 with aggressive expansion ahead; the latest print is steady, but the price already banks on this growth.
Overall read
6.0/10
Priced ahead of it
The three reads · this quarter
Franchisee count has hit a record 11,730 with aggressive expansion ahead; the latest print is steady, but the price already banks on this growth.
Overall read
6.0/10
Priced ahead of it
The three reads · this quarter
The standing reads · change less often
Moat
Slim edge
Key variables
3 tracked
lead: Franchisee network growth (active quarterly franchisees)Record franchisee base with strong quarterly additions indicates network momentum, though churn must be monitored for durability.
Walk the talk
Not enough data
as of Q1 FY27Specialty diagnostics (allergy, genomics, histopathology) commercially launched in Q1 FY27; target 15-20% of revenue in 3-5 years; initial investments already made.
Latest · newest first
1w ago · M&A / Investment
Promoter released pledge on equity shares of Thyrocare Technologies.
2w ago · M&A / Investment
Promoter Docon Technologies sold 15,769,696 equity shares of Thyrocare Technologies.
2w ago · M&A / Investment
Promoter released pledge on 17,500,000 equity shares of Thyrocare Technologies.
4w ago · Business Update
Transcript of earnings call for Q1 FY27 released.
23 Jul 2026 · M&A / Investment
Board to evaluate restructuring of radiology business.
1 of 2 guidance items delivered on time
Where it sits